Private equity firms Blackstone and TPG have agreed to acquire global women’s health technology business Hologic in a deal worth up to $18.3bn (c.£13.7bn). Under the deal, Blackstone and TPG will purchase all outstanding Hologic shares for $76 per share in cash, plus a non-tradable contingent value right (CVR) worth up to an additional $3…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
.){kind=link}